Article
Dosage of 6-Mercaptopurine in Relation to Genetic TPMT and ITPA Variants: Toward Individualized Pediatric Acute Lymphoblastic Leukemia Maintenance Treatment.
Journal of pediatric hematology/oncology - 1 Mar 2020
Kouwenberg Theodorus W, van den Bosch Bianca J C, Bierau Jörgen, Te Loo Dunja Maroeska W M, Coenen Marieke J H, Hagleitner Melanie M
Abstract excerpt
6-mercaptopurine (6-MP) is the mainstay in pediatric acute lymphoblastic leukemia (ALL) maintenance treatment. Variants in genes coding for thiopurine S-methyl transferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) are known to influence 6-MP metabolism. We determined TPMT and ITPA genotype and enzyme activity and the mean 6-MP doses during maintenance treatment in 40 children treated for ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
